| Net income including noncontrolling interest | 32.15M |
| Depreciation | 5.42M |
| Amortization | 2.94M |
| Stock compensation expense | 831K |
| Accounts receivable | 2.71M |
| Inventories | -12.09M |
| Accounts payable | -5.64M |
| Accrued expenses | -663K |
| Long-term liabilities | |
| Other | -1.08M |
| Net Cash and Cash Equivalents Provided (Used) by Operating Activities | 24.59M |
| Business acquisition, net of cash acquired | |
| Capital expenditures, net of nominal disposals | -5.07M |
| Net Cash and Cash Equivalents Used by Investing Activities | -5.07M |
| Proceeds from debt borrowings | |
| Repayments of debt | |
| Share repurchase program | 0 |
| Net proceeds from issuance of common stock, including stock option tax impact | |
| Cash dividends paid | -2.11M |
| Net Cash and Cash Equivalents (Used) Provided by Financing Activities | -2.16M |
| Exchange Rate Impact on Cash | 580K |
| Decrease in Cash and Cash Equivalents | 17.95M |
| Cash and Cash Equivalents at Beginning of Period | 166.93M |
| Cash and Cash Equivalents at End of Period | 184.87M |